Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Recurrent GBM (Phase 2)”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Study completedNCT02942264
What this trial is testing

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

Who this might be right for
Brain TumorAstrocytomaAstroglioma+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Looking for participantsNCT06356883
What this trial is testing

Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

Who this might be right for
Glioblastoma MultiformeRelapse
Université de Sherbrooke 120
Testing effectiveness (Phase 2)Looking for participantsNCT03672721
What this trial is testing

IA Carboplatin + Radiotherapy in Relapsing GBM

Who this might be right for
Glioblastoma MultiformeRelapse
Université de Sherbrooke 35
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Testing effectiveness (Phase 2)Study completedNCT00107237
What this trial is testing

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00016991
What this trial is testing

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Ended earlyNCT02765165
What this trial is testing

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)
Proximagen, LLC 26
Testing effectiveness (Phase 2)Study completedNCT00704288
What this trial is testing

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Exelixis 222
Testing effectiveness (Phase 2)Looking for participantsNCT02800486
What this trial is testing

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Who this might be right for
GlioblastomaAnaplastic AstrocytomaAnaplastic Oligoastrocytoma+6 more
Northwell Health 37
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01112527
What this trial is testing

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Who this might be right for
GlioblastomaGBMGlioblastoma Multiforme
Massachusetts General Hospital 58
Testing effectiveness (Phase 2)Study completedNCT00795665
What this trial is testing

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Who this might be right for
Glioma
University of California, Davis 7
Testing effectiveness (Phase 2)Study completedNCT00116376
What this trial is testing

Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Novartis Pharmaceuticals 64
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT02348255
What this trial is testing

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Who this might be right for
Adult Brain GlioblastomaRecurrent Adult Brain Neoplasm
University of California, Davis
Testing effectiveness (Phase 2)Ended earlyNCT01517776
What this trial is testing

Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents

Who this might be right for
Gliomas
Martin-Luther-Universität Halle-Wittenberg 28
Testing effectiveness (Phase 2)Study completedNCT01498328
What this trial is testing

Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

Who this might be right for
GlioblastomaSmall Cell GlioblastomaGiant Cell Glioblastoma+4 more
Celldex Therapeutics 127
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85